Q3 2025 Holdings
Filed 2025-11-14 | 13 holdings | $500.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $262.0M | 9,212,384 | 52.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $69.1M | 5,462,846 | 13.8% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $65.8M | 9,632,561 | 13.1% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $29.9M | 4,107,537 | 6.0% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $26.7M | 3,452,330 | 5.3% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $18.5M | 379,640 | 3.7% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $17.4M | 4,158,368 | 3.5% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $8.9M | 344,237 | 1.8% |
| Engene Holdings Inc(ENGNW) | W EXP 10/31/2028 | 29286M113 | $2.1M | 2,878,148 | 0.4% |